3854.T
I'LL inc.
TokyoJPYEQUITY
Technology
DELAYED
Last price
2,477.00
▼ 20.00 (0.80%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
2,497.00
Prev close
2,497.00
Day high
2,520.00
Day low
2,463.00
Volume
114.50K
Market cap
$61.92B
P/E (TTM)
15.75
52W range
2,120.00 – 3,090.00
Day trading desk
Gap from prior close
0.00%
Prior close 2,497.00
VWAP
2,482.48
-0.22% from price
Relative volume
1.04×
Normal
Session range
1.50%
2,463.00 – 2,500.00
Position in range
38%
Mid range
ATR (14D)
64.57
2.61% of price
Prior day high
2,499.00
PDH
Prior day low
2,436.00
PDL
Bid / ask spread
—
Quote not published
Session volume
102.20K
Avg 98.45K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.56%
+2.9%
1M
+7.23%
+3.5%
3M
-3.69%
-6.8%
6M
+7.93%
-3.1%
YTD
-2.67%
-15.0%
1Y
-14.08%
-34.1%
3Y
-6.00%
-80.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 3854.T open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
14.47M
Total on file
Fundamentals
Market cap$61.92B
Enterprise value$52.87B
Revenue (TTM)$20.74B
Gross profit$11.79B
EBITDA$5.98B
Net income$4.06B
EPS (TTM)$157.29
Free cash flow—
Total cash$9.05B
Total debt$0
Book value / share$500.88
Shares outstanding25.00M
Float10.13M
Short % of float—
Dividend yield2.66%
Beta (5Y)0.04
Valuation & profitability ratios
Trailing P/E15.75
Forward P/E31.57
PEG ratio—
Price / sales—
Price / book4.95
EV / revenue2.55
EV / EBITDA8.85
Gross margin56.84%
Operating margin27.19%
Profit margin19.59%
Return on equity37.42%
Return on assets21.57%
Debt / equity—
Current ratio4.64
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | — | $17.51B | $15.92B | $12.94B | — |
| Operating revenue | — | $17.51B | $15.92B | $12.94B | — |
| Cost of revenue | — | $7.74B | $7.24B | $6.21B | — |
| Gross profit | — | $9.77B | $8.68B | $6.74B | — |
| Total operating expense | — | $5.51B | $5.13B | $4.64B | — |
| Operating income | — | $4.26B | $3.55B | $2.10B | — |
| Net interest income | — | -$402.00K | -$695.00K | -$1.19M | — |
| Pre-tax income | — | $4.06B | $3.57B | $2.12B | — |
| Tax provision | — | $1.17B | $1.10B | $741.20M | — |
| Net income | — | $2.89B | $2.47B | $1.38B | — |
| Net income to common | — | $2.89B | $2.47B | $1.38B | — |
| Basic EPS | 141.32 | 115.36 | 98.76 | 55.04 | +22.5% |
| Diluted EPS | 141.32 | — | 98.76 | 55.04 | — |
| EBIT | — | $4.06B | $3.57B | $2.12B | — |
| EBITDA | — | $4.46B | $4.05B | $2.69B | — |
| Basic shares | 24.68M | 25.03M | 25.03M | 25.03M | -1.4% |
| Diluted shares | 24.68M | 25.03M | 25.03M | 25.03M | -1.4% |
| Line item | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $6.66B | $5.64B | $3.64B | +18.1% |
| Cash & short-term investments | $6.66B | $5.64B | $3.64B | +18.1% |
| Accounts receivable | $2.62B | $2.15B | $1.74B | +21.9% |
| Inventory | $292.87M | $258.93M | $244.03M | +13.1% |
| Total current assets | $11.57B | $9.68B | $7.25B | +19.6% |
| Property, plant & equipment | $583.36M | $560.59M | $464.87M | +4.1% |
| Goodwill & intangibles | $792.05M | $837.98M | $827.97M | -5.5% |
| Total assets | $14.15B | $12.12B | $9.58B | +16.8% |
| Total current liabilities | $2.56B | $2.55B | $2.13B | +0.3% |
| Total liabilities | $4.47B | $4.37B | $3.86B | +2.2% |
| Retained earnings | $8.96B | $6.98B | $5.03B | +28.5% |
| Shareholder equity | $9.68B | $7.74B | $5.72B | +25.1% |
| Working capital | $9.01B | $7.13B | $5.12B | +26.4% |
| Net tangible assets | $8.89B | $6.90B | $4.89B | +28.8% |
| Shares issued | 25.04M | 25.04M | 25.04M | 0.0% |
| Line item | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|
| Net income | $4.06B | $3.57B | $2.12B | +13.7% |
| Depreciation & amortisation | $402.18M | $478.96M | $574.35M | -16.0% |
| Stock-based compensation | $24.25M | $25.36M | $26.62M | -4.4% |
| Change in working capital | -$630.70M | -$346.88M | -$563.06M | -81.8% |
| Operating cash flow | $2.64B | $3.07B | $1.13B | -14.2% |
| Capital expenditure | -$612.21M | -$547.59M | -$481.81M | -11.8% |
| Investing cash flow | -$712.69M | -$547.41M | -$482.29M | -30.2% |
| Share buybacks | $0 | -$82.00K | -$125.00K | +100.0% |
| Dividends paid | -$900.90M | -$526.13M | -$450.51M | -71.2% |
| Financing cash flow | -$901.93M | -$526.21M | -$465.64M | -71.4% |
| Free cash flow | $2.03B | $2.53B | $652.34M | -19.8% |
| End cash position | $6.66B | $5.64B | $3.64B | +18.1% |
| Line item | 2025-10-31 | YoY |
|---|---|---|
| Basic EPS | 36.57 | |
| Diluted EPS | 36.57 | |
| Basic shares | 25.02M | |
| Diluted shares | 25.02M |
| Line item | 2026-01-31 | 2025-01-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $8.85B | — | — |
| Cash & short-term investments | $8.85B | — | — |
| Accounts receivable | $5.37B | — | — |
| Inventory | $151.33M | — | — |
| Total current assets | $14.60B | $11.31B | +29.1% |
| Property, plant & equipment | $576.91M | — | — |
| Goodwill & intangibles | $866.54M | — | — |
| Total assets | $17.28B | $13.82B | +25.1% |
| Total current liabilities | $2.98B | — | — |
| Total liabilities | $4.91B | — | — |
| Retained earnings | $11.65B | $9.74B | +19.6% |
| Shareholder equity | $12.37B | — | — |
| Working capital | $11.63B | $6.85B | +69.7% |
| Net tangible assets | $11.50B | $6.48B | +77.6% |
| Shares issued | 25.04M | 25.04M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Apr 2026 | — | 39.00 | — |
| Oct 2025 | — | 36.57 | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $5.47B | +5.3% |
| Next quarter | — | — | $0 | — |
| Current year | 165.40 | 2 | $21.02B | +11.6% |
| Next year | 178.00 | 2 | $23.00B | +9.5% |
Analyst targets & ownership
Mean target$3,000.00
High target$3,000.00
Low target$3,000.00
Implied upside21.11%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders57.88%
Held by institutions6.48%
Institutions holding43
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
2,378.90
+4.12% from price
SMA 20
2,319.85
+6.77% from price
SMA 50
2,298.02
+7.79% from price
SMA 100
2,365.88
+4.70% from price
SMA 200
2,395.07
+3.42% from price
EMA 12
2,384.78
+3.87% from price
EMA 26
2,347.65
+5.51% from price
EMA 50
2,341.38
+5.79% from price
RSI (14)
63.9
Neutral
MACD (12,26,9)
37.13
Hist 24.88
ATR (14)
64.57
2.61% of price
Realised vol 30D
28.4%
Annualised
Bollinger upper
2,501.51
20, 2σ
Bollinger lower
2,138.19
20, 2σ
50 / 200 cross
Death
2,298.02 vs 2,395.07
Trend bias
Above 200
+3.42%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.06
Less volatile than market
Correlation to SPY
-0.03
Largely independent
Realised vol 30D
28.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-29.5%
Peak to trough
Max drawdown 5Y
-51.8%
Peak to trough
ATR 14
64.57
2.61% of price
Beta (reported)
0.04
5Y monthly, from filing
Dividends & splits
Forward rate$66.00 / yr
Forward yield2.66%
5-year avg yield1.42%
Payout ratio39.42%
Ex-dividend dateJul 30, 2026
Next pay date—
Last split2:1
Split dateOct 30, 2019
Headlines
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Motley Fool · 5m ago
Vistra Is the Quietest Big Winner of the AI Power Boom. Here's Why.
Motley Fool · 6m ago
AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?
Insider Monkey · 6m ago
Uber faces fine of nearly $1B over automated driver suspensions
TechCrunch · 15m ago
This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It.
Motley Fool · 17m ago
This Chinese Tech Giant Quietly Cut Its Buyback 80% to Fund AI
24/7 Wall St. · 27m ago
Look Back: Long before Party on the Patio, Mötley Crüe rocked Pocono Downs
The Times-Leader (Wilkes-Barre, Pa.) · 28m ago
Prediction: ExxonMobil Raises Its Dividend More Than Wall Street Expects
Motley Fool · 29m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.